IRLAB Therapeutics AB (publ) (STO: IRLAB.A)
Sweden
· Delayed Price · Currency is SEK
12.95
-0.15 (-1.15%)
Oct 3, 2024, 4:49 PM CET
IRLAB Therapeutics AB Revenue
IRLAB Therapeutics AB had revenue of 42.78M SEK in the quarter ending June 30, 2024, with 522.66% growth. This brings the company's revenue in the last twelve months to 41.59M, up 16.96% year-over-year. In the year 2023, IRLAB Therapeutics AB had annual revenue of 5.68M, down -90.71%.
Revenue (ttm)
41.59M
Revenue Growth
+16.96%
P/S Ratio
15.97
Revenue / Employee
1.30M
Employees
34
Market Cap
663.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
Dec 31, 2021 | 207.78M | 207.48M | 69,160.67% |
Dec 31, 2020 | 300.00K | -72.00K | -19.35% |
Dec 31, 2019 | 372.00K | 176.00K | 89.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.17B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |